Noninvasive prenatal screening (NIPS) that uses cell-free DNA (cfDNA) from the plasma of pregnant women offers tremendous potential as a screening method for fetal aneuploidy. ACOG and SMFM recommended it as a screening option for women at increased risk of aneuploidy such as AMA, or women with positive first or second trimester screening test results.
Email: info@carnegieimaging.com
Hours: M-F / 9AM - 5PM
Please be advised that neither physicians nor nurses can provide medical opinions or consultations via email. Email inquiries should be limited to general questions. We have provided information on this site under Patient Resources that covers many topics related to our specialty to assist you with questions on specific topics.
Contact Us
Carnegie South
212 427-1576
Carnegie Hill 212 722-7426
212-235-1506
